Evidence map›Paper›PMID 18465769›Full record

ArticleEuropean journal of immunology2008

Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.

David S Riddle, Peter J Miller, Benjamin G Vincent, Thomas B Kepler, Rob Maile, Jeffrey A Frelinger, Edward J Collins

Abstract read
In one paragraph

Article in European journal of immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The CD8α-PILRα interaction maintains CD8Science (New York, N.Y.) · 2022
    Article
  2. Article
  3. Duality of the murine CD8 compartment.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David S RiddleUniversity of North Carolina at Chapel Hill, Department of Microbiology and Immunology, Chapel Hill, NC 27599-7290, USA.
Peter J Miller
Benjamin G Vincent
Thomas B Kepler
Rob Maile
Jeffrey A Frelinger
Edward J Collins

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Role of the MHC Class I in CD8 T Cell ActivationR01GM067143 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI FRELINGER, JEFFREY ALLEN · 2002 to 2005
$1.4M
Peptide Binding to Class I MHCR01CA092368 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLLINS, EDWARD JOHN · 2003 to 2006
$1.3M
NCI NIH HHS CA 92368-02NCI NIH HHS R01 CA092368NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI 50410NIGMS NIH HHS GM 67143-21NIGMS NIH HHS R01 GM067143
6 · The paper itself

Abstract

CD8 plays an important role in the activity of cytolytic T cells (CTL). However, whether or not CD8 is required for the development of CTL has not been clearly determined. Cytotoxic activity in the CD8alpha knockout mouse is difficult to induce, and has only been demonstrated against allogenic MHC targets. The lack of cytotoxicity may result from impaired lineage commitment of CTL in the absence of CD8, or diminished competitiveness during selection against (unimpaired) development of CD4(+) T cells on MHC class II (MHC II). To differentiate between these possibilities, we have generated a double-knockout mouse (MHC II(-/-)CD8alpha(-/-)). In MHC II(-/-)CD8alpha(-/-) mice, developing MHC class I (MHC I)-reactive thymocytes cannot rely upon CD8 for selection, but they also cannot be overwhelmed by efficient selection of MHC II-reactive thymocytes. In this mouse, a large, heterogeneous population of peripheral coreceptor double-negative (DN) and CD4(+) T cells develops. Peripheral DN T cells are fully functional CTL. They display cytolytic activity against allogeneic MHC, and against syngeneic MHC following lymphocytic choriomeningitis virus (LCMV) infection. Cells from LCMV-infected mice bind more MHC I tetramer at lower concentrations than their wild-type CTL counterparts. These results demonstrate unequivocally that CD8 is not required for commitment of thymocytes to the CTL lineage.

Indexed as

AnimalsAntigens, ViralCD4-Positive T-LymphocytesCD8 AntigensCell CountComplementarity Determining RegionsEpitopes, T-LymphocyteGlycoproteinsGraft SurvivalHistocompatibility Antigens Class IILymphocyte Culture Test, MixedLymphocytic ChoriomeningitisMiceMice, Inbred BALB CMice, Inbred StrainsMice, KnockoutAntigens, ViralCD8 antigen, alpha chainCD8 AntigensComplementarity Determining RegionsEpitopes, T-Lymphocyteglycoprotein peptide 33-41, Lymphocytic choriomeningitis virusGlycoproteinsHistocompatibility Antigens Class IIPeptide FragmentsReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaViral Proteins

Identifiers

PMID18465769
PMCPMC2957804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.